If the population with cytoplasmic CD133 expression could be shown to serve a role as stem cells in the normal tissue, it would become an interesting candidate for the transformation to tumor-initiating cells in pancreatic cancer. The gene discussed is PROM1; the disease is pancreatic neoplasm.